brivudine and its Impurities

Brivudine is used for the treatment of herpes zoster in adult patients. Brivudine is an antiviral drug.. Reference standards of Brivudine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 14 results for brivudine Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 29 22000

Brivudine

Brivudine

  • Catalogue No.:PA 29 22000

  • CAS :

    69304-47-8

  • Molecular Formula : C11H13BrN2O5

  • Molecular Weight : 333.14

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 22510

α-(Z)-Brivudine

α-(Z)-Brivudine

  • Catalogue No.:PA 29 22510

  • CAS :

    NA

  • Molecular Formula : C11H13BrN2O5

  • Molecular Weight : 333.14

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 22520

β-(Z)-Brivudine

β-(Z)-Brivudine

  • Catalogue No.:PA 29 22520

  • CAS :

    77530-02-0

  • Molecular Formula : C11H13BrN2O5

  • Molecular Weight : 333.14

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 22530

((2R,3S,5R)-3-Acetoxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl Acetate

((2R,3S,5R)-3-Acetoxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl Acetate

  • Catalogue No.:PA 29 22530

  • CAS :

    6979-97-1

  • Molecular Formula : C14H18N2O7

  • Molecular Weight : 326.31

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 22540

(E)-3-(1-((2R,4S,5R)-4-acetoxy-5-(acetoxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylic Acid

(E)-3-(1-((2R,4S,5R)-4-acetoxy-5-(acetoxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylic Acid

  • Catalogue No.:PA 29 22540

  • CAS :

    NA

  • Molecular Formula : C16H18N2O9

  • Molecular Weight : 382.33

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 22550

5-(2,2-Dibromovinyl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

5-(2,2-Dibromovinyl)-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

  • Catalogue No.:PA 29 22550

  • CAS :

    61135-36-2

  • Molecular Formula : C11H12Br2N2O5

  • Molecular Weight : 412.03

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 0221000

1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde

1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde

  • Catalogue No.:PA 29 0221000

  • CAS :

    4494-26-2

  • Molecular Formula : C10H12N2O6

  • Molecular Weight : 256.21

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 0221004

Uridine 5′-(tetrahydrogen triphosphate), 5-[(1E)-2-bromoethenyl]-2′-deoxy

Uridine 5′-(tetrahydrogen triphosphate), 5-[(1E)-2-bromoethenyl]-2′-deoxy

  • Catalogue No.:PA 29 0221004

  • CAS :

    77222-61-8

  • Molecular Formula : C11H16BrN2O14P3

  • Molecular Weight : 573.07

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 0221003

6-Aza-UTP

6-Aza-UTP

  • Catalogue No.:PA 29 0221003

  • CAS :

    6198-30-7

  • Molecular Formula : C8H14N3O15P3

  • Molecular Weight : 485.13

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 0221002

7-Deaza-2'-C-acetylene-adenosine

7-Deaza-2'-C-acetylene-adenosine

  • Catalogue No.:PA 29 0221002

  • CAS :

    1044589-82-3

  • Molecular Formula : C13H14N4O4

  • Molecular Weight : 290.28

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 0221001

7-[2-C-Ethynyl-5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine

7-[2-C-Ethynyl-5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-β-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine

  • Catalogue No.:PA 29 0221001

  • CAS :

    1291103-01-9

  • Molecular Formula : C13H17N4O13P3

  • Molecular Weight : 530.22

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 0221005

(E)-5-(2-Bromovinyl)Pyrimidine-2,4(1H,3H)-dione

(E)-5-(2-Bromovinyl)Pyrimidine-2,4(1H,3H)-dione

  • Catalogue No.:PA 29 0221005

  • CAS :

    69304-49-0

  • Molecular Formula : C6H5BrN2O2

  • Molecular Weight : 217.02

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 0221006

(2R,3S,5R)-5-(5-((E)-2-Bromovinyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(((4-chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzoate

(2R,3S,5R)-5-(5-((E)-2-Bromovinyl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-(((4-chlorobenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-chlorobenzoate

  • Catalogue No.:PA 29 0221006

  • CAS :

    87531-10-0

  • Molecular Formula : C25H19BrCl2N2O7

  • Molecular Weight : 610.24

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 29 0221007

7-Bromo-6-((E)-2-bromovinyl)-2-((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-8-(1-((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2,4-diazabicyclo[4.2.0]octane-3,5-dione

7-Bromo-6-((E)-2-bromovinyl)-2-((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-8-(1-((2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-2,4-diazabicyclo[4.2.0]octane-3,5-dione

  • Catalogue No.:PA 29 0221007

  • CAS :

    NA

  • Molecular Formula : C22H26Br2N4O10

  • Molecular Weight : 666.28

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
pharmaffiliates